tradingkey.logo

Ingevity Corp

NGVT
55.010USD
-1.300-2.31%
Close 10/03, 16:00ETQuotes delayed by 15 min
2.01BMarket Cap
LossP/E TTM

Ingevity Corp

55.010
-1.300-2.31%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Ingevity Corp

Currency: USD Updated: 2025-10-03

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Ingevity Corp's Score

Industry at a Glance

Industry Ranking
16 / 72
Overall Ranking
122 / 4706
Industry
Chemicals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
65.250
Target Price
+15.88%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Ingevity Corp Highlights

StrengthsRisks
Ingevity Corporation is engaged in developing, marketing, and bringing to market solutions that are renewably sourced. The Company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Performance Materials segment engineers, manufactures, and sells hardwood-based, chemically activated carbon products, which are produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Performance Chemicals segment is comprised of two product lines: road technologies and industrial specialties. Its products are utilized in pavement construction, preservation, reconstruction and recycling, agrochemical dispersants, paper chemicals and other diverse industrial uses. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.
Overvalued
The company’s latest PB is 16.62, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 35.88M shares, increasing 1.91% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 1.10M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.33.

Financial Health

Currency: USD Updated: 2025-10-03

The company's current financial score is 7.62, which is higher than the Chemicals industry's average of 7.40. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 365.10M, representing a year-over-year decrease of 6.53%, while its net profit experienced a year-over-year decrease of 48.36%.

Score

Industry at a Glance

Previous score
7.62
Change
0

Financials

5.95

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

6.25

Operational Efficiency

8.95

Growth Potential

10.00

Shareholder Returns

6.94

Ingevity Corp's Company Valuation

Currency: USD Updated: 2025-10-03

The company’s current valuation score is 7.68, which is higher than the Chemicals industry's average of 7.48. Its current P/E ratio is -9.25, which is -277.09% below the recent high of 16.37 and -3478.16% above the recent low of -330.83.

Score

Industry at a Glance

Previous score
7.68
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 16/72
No Data

Earnings Forecast

Currency: USD Updated: 2025-10-03

The company’s current earnings forecast score is 8.00, which is higher than the Chemicals industry's average of 7.26. The average price target for Ingevity Corp is 69.00, with a high of 71.00 and a low of 52.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts
Buy
Current Rating
65.250
Target Price
+15.88%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

8
Total
5
Median
7
Average
Company name
Ratings
Analysts
Ingevity Corp
NGVT
4
Huntsman Corp
HUN
17
Ashland Inc
ASH
13
Chemours Co
CC
10
Ecovyst Inc
ECVT
6
LSB Industries Inc
LXU
4
1
2

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-03

The company’s current price momentum score is 6.49, which is lower than the Chemicals industry's average of 7.00. Sideways: Currently, the stock price is trading between the resistance level at 59.25 and the support level at 52.30, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.79
Change
-0.3

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.792
Neutral
RSI(14)
47.511
Neutral
STOCH(KDJ)(9,3,3)
35.027
Neutral
ATR(14)
1.773
Low Volatility
CCI(14)
-9.278
Neutral
Williams %R
75.234
Sell
TRIX(12,20)
-0.091
Sell
StochRSI(14)
36.400
Sell
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
55.092
Sell
MA10
55.307
Sell
MA20
56.619
Sell
MA50
54.112
Buy
MA100
48.921
Buy
MA200
44.991
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-03

The company’s current institutional recognition score is 10.00, which is higher than the Chemicals industry's average of 6.83. The latest institutional shareholding proportion is 98.40%, representing a quarter-over-quarter decrease of 5.99%. The largest institutional shareholder is The Vanguard, holding a total of 4.09M shares, representing 11.21% of shares outstanding, with 2.00% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
5.24M
-1.28%
The Vanguard Group, Inc.
Star Investors
4.09M
+0.27%
Wellington Management Company, LLP
2.18M
-5.09%
American Century Investment Management, Inc.
1.71M
+15.61%
State Street Global Advisors (US)
1.50M
-3.20%
Segall Bryant & Hamill, LLC
1.28M
+0.31%
Millennium Management LLC
1.17M
-4.26%
Thrivent Asset Management, LLC
1.14M
-8.25%
Royce Investment Partners
Star Investors
1.10M
-9.03%
Brown Advisory
928.84K
-1.06%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-03

The company’s current risk assessment score is 6.11, which is higher than the Chemicals industry's average of 6.10. The company's beta value is 1.46. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
6.11
Change
0
Beta vs S&P 500 index
1.46
VaR
+3.64%
240-Day Maximum Drawdown
+40.49%
240-Day Volatility
+53.78%

Return

Best Daily Return
60 days
+21.32%
120 days
+21.32%
5 years
+21.32%
Worst Daily Return
60 days
-4.11%
120 days
-4.11%
5 years
-14.05%
Sharpe Ratio
60 days
+1.38
120 days
+2.68
5 years
+0.08

Risk Assessment

Maximum Drawdown
240 days
+40.49%
3 years
+67.07%
5 years
+67.07%
Return-to-Drawdown Ratio
240 days
+1.36
3 years
-0.14
5 years
-0.07
Skewness
240 days
+1.57
3 years
+0.78
5 years
+0.63

Volatility

Realised Volatility
240 days
+53.78%
5 years
+42.60%
Standardised True Range
240 days
+3.32%
5 years
+3.67%
Downside Risk-Adjusted Return
120 days
+717.95%
240 days
+717.95%
Maximum Daily Upside Volatility
60 days
+47.94%
Maximum Daily Downside Volatility
60 days
+34.97%

Liquidity

Average Turnover Rate
60 days
+0.70%
120 days
+0.74%
5 years
--
Turnover Deviation
20 days
+33.18%
60 days
-4.04%
120 days
+0.50%

Peer Comparison

Chemicals
Ingevity Corp
Ingevity Corp
NGVT
7.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CF Industries Holdings Inc
CF Industries Holdings Inc
CF
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cabot Corp
Cabot Corp
CBT
8.15 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Koppers Holdings Inc
Koppers Holdings Inc
KOP
8.15 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Nutrien Ltd
Nutrien Ltd
NTR
8.14 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Element Solutions Inc
Element Solutions Inc
ESI
8.11 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI